
Genprex Announces the Opening for Enrollment of its Phase 1/2 Acclaim-2 Clinical Trial of REQORSA(TM) Immunogene Therapy in Combination With Keytruda® to Treat Non-Small Cell Lung Cancer
March 31, 2022
Host Chris Miglino interviews CFO Jim Heindlmeyer.
March 31, 2022
March 10, 2023
March 14, 2022
June 18, 2024
We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.